Project

Oral delivery of semaglutide through multifunctional FcRn-peptide targeting nanoparticles for treatment of type 2 diabetes mellitus

Staff View

Reference:	SFRH/BD/144719/2019
Funding organization:	Fundação para a Ciência e a Tecnologia
Associated institutions:	Instituto Politécnico do Porto